Page last updated: 2024-11-02

oxybutynin and B16 Melanoma

oxybutynin has been researched along with B16 Melanoma in 3 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Singh, P1
Zeng, X1
Chen, X1
Yang, Y1
Chen, Y1
Cui, S1
Carrier, A1
Oakes, K1
Luan, T1
Zhang, X1
Saxena, SK1
Pandey, U1
Kumar, Y1
Chakravarty, R1
Sarma, HD1
Dash, A1
Wang, L1
Lu, AP1
Yu, ZL1
Wong, RN1
Bian, ZX1
Kwok, HH1
Yue, PY1
Zhou, LM1
Chen, H1
Xu, M1
Yang, Z1

Other Studies

3 other studies available for oxybutynin and B16 Melanoma

ArticleYear
Quantitation of polymeric-microneedle-delivered HA15 in tissues using liquid chromatography-tandem mass spectrometry.
    Journal of pharmaceutical and biomedical analysis, 2020, Jun-05, Volume: 185

    Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutic

2020
On the application of Nafion membrane for the preparation of (90)Y skin patches, quality control, and biological evaluation for treatment of superficial tumors.
    Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:5

    Topics: Animals; Fluorocarbon Polymers; Melanoma, Experimental; Membranes, Artificial; Mice; Mice, Inbred C5

2014
The melanogenesis-inhibitory effect and the percutaneous formulation of ginsenoside Rb1.
    AAPS PharmSciTech, 2014, Volume: 15, Issue:5

    Topics: Administration, Cutaneous; Animals; Cell Line, Tumor; Cell Survival; Collagen; Delayed-Action Prepar

2014